pharmaceutical investing Pfizer Granted FDA Breakthrough Therapy Designation for 20-Valent Pneumococcal Conjugate Vaccine
pharmaceutical investing Rhythm Pharmaceuticals Completes Pivotal Enrollment in Two Ongoing Phase 3 Clinical Trials
SAGA Metals Announces Expiry of Warrant Acceleration Program and Receipt of C$3,422,888 in Warrant Proceeds since January 1, 2026
